Joann Stavole

Joann Stavole, MS, RAC (US), serves as Vice President of Regulatory Affairs & Quality Assurance at RVL Pharmaceuticals since August 2021, following a tenure as Senior Director of Regulatory Affairs at Osmotica Pharmaceutical Corp. from December 2017 to September 2021. Prior roles include Senior Director of Regulatory Affairs at Teva Pharmaceuticals and Director of Regulatory Affairs at Actavis, where responsibilities encompassed overseeing teams and managing pre-approval activities, third-party products, and foreign site manufacturing for the US market. Joann's extensive regulatory experience began at Alpharma Pharmaceuticals as Associate Director of Regulatory Affairs. Educational qualifications include a Master of Science in Regulatory Affairs from Northeastern College of Professional Studies and a BA in English with a minor in Chemistry from Rutgers University.